Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Asset Utilization Ratio (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.93 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 14.61% year-over-year to 0.93; the TTM value through Mar 2026 reached 0.93, up 14.61%, while the annual FY2025 figure was 0.91, 1.67% down from the prior year.
  • Asset Utilization Ratio hit 0.93 in Q1 2026 for Corcept Therapeutics, up from 0.92 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.93 in Q1 2026 and bottomed at 0.69 in Q1 2023.
  • Average Asset Utilization Ratio over 5 years is 0.82, with a median of 0.82 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio soared 40.93% in 2022 and then fell 19.2% in 2023.
  • Corcept Therapeutics' Asset Utilization Ratio stood at 0.72 in 2022, then increased by 10.27% to 0.79 in 2023, then rose by 4.69% to 0.83 in 2024, then increased by 10.39% to 0.92 in 2025, then increased by 1.54% to 0.93 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.93, 0.92, and 0.91 for Q1 2026, Q4 2025, and Q3 2025 respectively.